Inactive Instrument

Hong Kong Life Sciences and Technologies Group Limited Stock

Equities

8085

KYG4642K1040

Iron & Steel

Dynamic Chart
Hong Kong Life Sciences and Technologies Group Limited Auditor Raises 'Going Concern' Doubt CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Hong Kong Life Sciences and Technologies Group Limited Provides Earnings Guidance for the Three Months Ended 30 June 2020 CI
Hong Kong Life Sciences and Technologies Group Limited Provides Earnings Guidance for the Full Year Ended March 31, 2020 CI
Hong Kong Life Sciences and Technologies Group Limited Announces Unaudited Consolidated Earnings Results for the Third Quarter Ended December 31, 2019 CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
Hong Kong Life Sciences and Technologies Group Limited Provides Earnings Guidance for the Three Months Ended June 30, 2019 CI
Hong Kong Life Sciences and Technologies Group Limited Announces Consolidated Earnings Results for the Year Ended March 31, 2019 CI
Hong Kong Life Sciences and Technologies Group Limited Announces Earnings Guidance for the Year Ended 31 March 2019 CI
ZMAY Holdings Limited Accepts Fitting-Out Contract of the Contractor in Respect of the Fitting-Out Works to Be Carried Out At New Office and Customer Service Centre At the Contract Price CI
Hong Kong Life Sciences and Technologies Group Limited Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018 CI
Hong Kong Life Sciences and Technologies Group Limited Appoints Lau Ngai Cheung as Executive Director CI
Hong Kong Life Sciences and Technologies Group Limited Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018 CI
More news
Managers TitleAgeSince
Chief Executive Officer 49 11-09-29
Director/Board Member 57 09-10-18
Corporate Officer/Principal 38 16-02-29
Members of the board TitleAgeSince
Director/Board Member 57 09-10-18
Chief Executive Officer 49 11-09-29
Director/Board Member 59 19-01-24
More insiders
Hong Kong Life Sciences and Technologies Group Ltd. is an investment holding company principally engaged in the electronic components and metals trading business. The Company operates through four business segments. The Anti-aging and Stem Cell Technology Businesses segment is engaged in the provision of anti-aging services, health check and beauty services and the distribution of biomedical and life science products. The Trading Business segment is engaged in the trading of electronic components and metals. The Money Lending Business segment is engaged in the provision loan financing services. The Securities Investment Business segment is engaged in the trading and investment of securities.
More about the company